Fulgent Genetics acquiring Inform Diagnostics for $170M

Genetic testing company Fulgent Genetics has agreed to acquire pathology lab Inform Diagnostics for $170 million.

Advertisement

Inform Diagnostics is one of the largest national pathology labs in the U.S. and offers services including gastrointestinal pathology, dermatopathology, urologic pathology and hematopathology. It provides services to about 1,300 clients who represent 2,700 physicians.

Fulgent said April 18 that the deal is expected to close in the second quarter of 2022. The acquisition would  bolster Fulgent’s testing capabilities, sales force and managed care contracts and expand Fulgent’s footprint to labs in New York, Arizona, Massachusetts and Texas.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Lab

Advertisement

Comments are closed.